Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship - Priority Announcement - Inflammatory Bowel Disease

University of Alberta

$45,000.00

Effects of bacterial DNA on innate and adaptive immune responses during intestinal inflammation

FY 2009-10

Summary
Crohn's disease and ulcerative colitis are two uncurable inflammatory bowel diseases (IBD) affecting approximately 200,000 Canadians. Probiotics are live bacteria that when consumed in adequate amounts, confer health benefits on the host and are used in the treatment of IBD. It still remains to be determined how probiotics act on the immune system to decrease the inflammation seen in IBD. DNA isolated from probiotic bacteria can also have similar health benefits as live probiotics. This research will attempt to understand how DNA isolated from probiotic bacteria interacts with specific cells of our immune system in the large intestine. It is directly related to the study of these diseases in humans as we will be examining how DNA from probiotic bacteria interact with epithelial cells isolated from biopsies obtained from patients suffering from both Crohn's disease and ulcerative colitis.Understanding how the components of probiotic bacteria interact with our immune system will allow us to design more specific therapies to treat those suffering from Crohn's disease and ulcerative colitis, increasing their quality of life.
Program
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
194280
Name
Albert Eric J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Effects of bacterial DNA on innate and adaptive immune responses during intestinal inflammation
Programtype2
Fellowship Programs
Orgnameinp2
University of Alberta
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Keyworddelim
Adaptive Immunity; Bacterial Dna; Colitis; Gastroenterology; Inflammation; Inflammatory Bowel Disease; Innate Immunity; Probiotics; T Cells; Toll-Like Receptor 9
Abstract
Crohn's disease and ulcerative colitis are two uncurable inflammatory bowel diseases (IBD) affecting approximately 200,000 Canadians. Probiotics are live bacteria that when consumed in adequate amounts, confer health benefits on the host and are used in the treatment of IBD. It still remains to be determined how probiotics act on the immune system to decrease the inflammation seen in IBD. DNA isolated from probiotic bacteria can also have similar health benefits as live probiotics. This research will attempt to understand how DNA isolated from probiotic bacteria interacts with specific cells of our immune system in the large intestine. It is directly related to the study of these diseases in humans as we will be examining how DNA from probiotic bacteria interact with epithelial cells isolated from biopsies obtained from patients suffering from both Crohn's disease and ulcerative colitis.Understanding how the components of probiotic bacteria interact with our immune system will allow us to design more specific therapies to treat those suffering from Crohn's disease and ulcerative colitis, increasing their quality of life.
Competitiondate
200910
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Albert, Eric J
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Infection & Immunity~ $21,250~ $0~Inst of Nutr Metabolism &Diab~ $22,500~ $0~Patient Oriented Research~ $1,250~ $0~